HAZEL ROSE KING: Open Payments
NPI 1558905356 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 16 payments from 12 companies in 2025. Trend: 2023 $545 · 2024 $419 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Novo Nordisk Inc | 2 | $39 |
| Corcept Therapeutics | 1 | $33 |
| Hologic Sales and Service, LLC | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $20 |
Products named: QULIPTA, JARDIANCE, Korlym, APTIMA, AIRSUPRA, GEMTESA, Dexcom G6 Transmitter, EVENITY.
Industry payments across WA — which companies pay providers there.
